Tarlatamab-Dlle. 1 mg, 10 mg Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 1 mg, 10 mg
Reference Brands: Imdelltra (USA), Imdylltra (EU/UK)
Category: Oncology Cancer Care
Tarlatamab-dlle is a bispecific T-cell engager (BiTE) antibody that binds DLL3 on small cell lung cancer cells and CD3 on T cells, enabling targeted immune killing of tumor cells. It is approved for adults with extensive-stage small cell lung cancer who have progressed after platinum-based chemotherapy. It has shown meaningful response rates and durable clinical benefit in resistant disease. The treatment is given by step-up intravenous infusion to reduce the risk of cytokine release syndrome. Patients are monitored closely for immune-related reactions and neurological side effects.
Tarlatamab-Dlle. — third party manufacturing & bulk supply
Tarlatamab-Dlle. 1 mg, 10 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Tarlatamab-Dlle. listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Tarlatamab-Dlle. →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Tarlatamab-dlle is used for the treatment of extensive-stage small cell lung cancer (ES-SCLC) in adults who have disease progression after platinum-based chemotherapy.
It is made from a bispecific T-cell engager (BiTE) antibody construct that binds to DLL3 on tumor cells and CD3 on T-cells to trigger targeted immune-mediated killing.
The trade name is Imdelltra.
It is manufactured and marketed by Amgen Inc.
The generic name is tarlatamab-dlle.
The brand name is Imdelltra.
It is manufactured by Amgen at its biologics production facilities in the United States.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
